Syndax Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, SNDX, Syndax Pharmaceuticals Inc, priceseries

Syndax Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
15.21
Close
16.47
High
16.63
Low
15.21
Previous Close
15.25
Daily Price Gain
1.22
YTD High
22.27
YTD High Date
Jan 3, 2022
YTD Low
14.56
YTD Low Date
Jan 28, 2022
YTD Price Change
-5.68
YTD Gain
-25.64%
52 Week High
25.68
52 Week High Date
Mar 24, 2021
52 Week Low
13.02
52 Week Low Date
Apr 21, 2021
52 Week Price Change
-6.83
52 Week Gain
-29.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 10. 2017
7.81
Jan 11. 2017
8.20
1 Trading Days
5.04%
Link
LONG
Jan 30. 2017
7.49
Feb 24. 2017
10.36
18 Trading Days
38.38%
Link
LONG
Mar 8. 2017
12.44
Mar 21. 2017
13.48
9 Trading Days
8.32%
Link
LONG
May 15. 2017
9.04
May 30. 2017
12.87
10 Trading Days
42.38%
Link
LONG
Jun 16. 2017
11.20
Jul 3. 2017
13.14
11 Trading Days
17.33%
Link
LONG
Mar 12. 2018
10.00
Mar 28. 2018
13.66
12 Trading Days
36.58%
Link
LONG
Jan 4. 2019
4.94
Jan 18. 2019
5.90
10 Trading Days
19.53%
Link
LONG
Jan 31. 2019
5.60
Feb 27. 2019
6.20
18 Trading Days
10.74%
Link
LONG
Apr 2. 2019
5.15
May 2. 2019
6.91
21 Trading Days
34.11%
Link
LONG
Jun 14. 2019
7.71
Jun 25. 2019
8.44
7 Trading Days
9.51%
Link
LONG
Dec 4. 2019
7.25
Dec 18. 2019
8.37
10 Trading Days
15.48%
Link
LONG
Feb 12. 2020
9.47
Feb 28. 2020
10.03
11 Trading Days
5.95%
Link
LONG
Apr 22. 2020
11.10
May 22. 2020
17.00
22 Trading Days
53.15%
Link
LONG
Aug 12. 2020
15.20
Aug 26. 2020
16.44
10 Trading Days
8.16%
Link
LONG
Sep 30. 2020
14.76
Oct 9. 2020
16.06
7 Trading Days
8.79%
Link
LONG
Nov 12. 2020
20.68
Dec 2. 2020
21.88
13 Trading Days
5.78%
Link
LONG
May 11. 2021
16.04
May 25. 2021
17.63
10 Trading Days
9.92%
Link
LONG
Aug 20. 2021
15.75
Sep 7. 2021
17.31
11 Trading Days
9.90%
Link
LONG
Dec 17. 2021
20.19
Jan 4. 2022
21.32
11 Trading Days
5.58%
Link
Company Information
Stock Symbol
SNDX
Exchange
NasdaqGS
Company URL
http://www.syndax.com
Company Phone
781-419-1400
CEO
Briggs W. Morrison
Headquarters
Massachusetts
Business Address
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA 02451
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001395937
About

Syndax Pharmaceuticals, Inc. operates as a clinical development oncology company with a platform based on an epigenetic approach to overcoming the problem of resistance in cancer therapy. It focuses on the development and commercialization of its lead product candidate, entinostat, an epigenetic therapy for treatment-resistant cancers. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Description

Developing a therapy that enhances checkpoint immuno-oncology drugs.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading